0001213900-20-016319.txt : 20200630
0001213900-20-016319.hdr.sgml : 20200630
20200630161736
ACCESSION NUMBER: 0001213900-20-016319
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200626
FILED AS OF DATE: 20200630
DATE AS OF CHANGE: 20200630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Praill Anthony Scott
CENTRAL INDEX KEY: 0001332948
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37823
FILM NUMBER: 201002525
MAIL ADDRESS:
STREET 1: 2001-889 HOMER STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6B 5S3
FORMER NAME:
FORMER CONFORMED NAME: Praill Scott
DATE OF NAME CHANGE: 20050713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DelMar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001498382
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 990360497
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 12707 HIGH BLUFF DR., SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 350-4364
MAIL ADDRESS:
STREET 1: 12707 HIGH BLUFF DR., SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Berry Only Inc.
DATE OF NAME CHANGE: 20100805
4
1
ownership.xml
X0306
4
2020-06-26
0
0001498382
DelMar Pharmaceuticals, Inc.
DMPI
0001332948
Praill Anthony Scott
12707 HIGH BLUFF DR.
SUITE 200
SAN DIEGO
CA
92130
0
1
0
0
Chief Financial Officer
Common Stock
2020-06-30
4
J
0
22
0
A
7474
D
Option (Right to Buy)
0.61
2020-06-26
4
A
0
57170
0
A
2029-09-05
Common Stock
57170
108366
D
The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
On September 5, 2019, the reporting person received options to purchase 57,170 shares which were subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the 2020 Annual Meeting of Stockholders. Stockholder approval of the increase was obtained on June 26, 2020.
1/6th of the options vested on March 5, 2020 with the remaining shares vesting in equal monthly installments over a period of 30 months which commenced on April 5, 2020.
/s/ Anthony Scott Praill
2020-06-30